Abstract Management of intracranial aneurysms continues to evolve, with coiling of aneurysms becoming an increasingly used modality. However, for aneurysms which are considered to be ''complex'' due to their size, position, or morphology, clipping continues to be the preferred treatment option. Several techniques can be utilized intraoperatively to facilitate aneurysm exposure and clip ligation. These include deep hypothermic circulatory arrest, endovascular balloon occlusion with suction, and, most commonly, temporary clip application to the proximal feeding vessel. The use of these techniques has been limited by the associated significant morbidity and mortality, and in the case of temporary clipping, anatomic limitations preventing clip application in certain cases. Recently, adenosine induced transient circulatory arrest has undergone a resurgence in neurosurgical practice to assist in complex aneurysm clip ligation. In this article we review this technique with special emphasis on appropriate patient selection and safety profile.
Introduction
The prevalence of intracranial aneurysms is 5 % in the general population [1] . The annual rate of aneurysmal rupture is approximately 6-8 per 100,000 (around 30,000 per year in the United states alone) [2] . Although coiling of intracranial aneurysms has grown in popularity in the past few years, open craniotomy and clip ligation continues to remain a commonly performed treatment modality. Open treatment of cerebral aneurysms usually involves initial placement of a temporary clip across a proximal feeding artery in order to decrease intra-aneurysmal turgor, thereby facilitating permanent clip placement. Certain intracranial aneurysm locations, such as a paraclinoid aneurysm, are difficult to treat with open clip ligation due to an inability to expose an anatomically suitable site for temporary clip placement [3, 4] . In these cases, innovative and novel techniques like deep hypothermic circulatory arrest, extracranial to intracranial bypass or endovascular balloon occlusion with suction have been employed to clip ligate the intracranial aneurysm [5] [6] [7] . Disadvantages of these techniques include a need for significant logistical support and the prevalence of complications like dissection of friable arteries, cerebro-embolic events and coagulopathy-associated intracranial hematomas [5] .
Adenosine is an endogenous purine nucleoside, which comprises a molecule of adenine attached to a ribose sugar (ribofuranose) moiety via a b-N 9 -glycosidic bond [8] .
Adenosine is essential for several biological processes including intracellular signal transduction (via cyclic adenosine-monophosphate) and energy transfer (via adenosine-triphosphate and adenosine-diphosphate). It also serves a function as an inhibitory neurotransmitter in the central nervous system, playing a role in sleep and arousal [8] . Many of the biological effects of adenosine (including those effecting sleep) are mediated via its action on adenosine receptors located in various tissues [9] . The effect of intravenously administered adenosine on animal hearts has been known since the early 20th century. In 1930, Honey et al. [10] studied the effects of intravenous adenosine on the human atrioventricular node, but it was not until 1955 that adenosine (as adenosine triphosphate) was used to terminate paroxysmal supraventricular tachycardia (PSVT). The FDA first approved the use of adenosine for treatment of PSVT in 1989, and within few years it replaced verapamil as the drug of choice for this indication [11] .
The use of intravenous adenosine infusion (as Adenosine triphosphate) to facilitate hypotensive anesthesia in humans was first reported in 1982 [12] . Two years later, Sollevi et al. [13] were able to demonstrate that adenosine administered as an infusion of ATP was an easily titratable drug to induce hypotensive anesthesia during cerebral aneurysm surgery by virtue of its short half-life (10-20 s). Adenosine induced flow arrest was first described by Groff et al. [14 • ] to assist clipping of a basilar artery aneurysm. Recently, several case series reporting the use of adenosine to facilitate cerebral aneurysm surgery have been published, which unlike the technique described by Sollevi et al., utilize adenosine boluses rather than an infusion to produce brief periods of severe bradycardia/hypotension and flow arrest [15 
The reduction in intraaneurysmal tension produced by an adenosine-induced flow arrest allows the surgeon to dissect the aneurysmal plane and appropriately place temporary or permanent clips.
Patient Selection: Indication and Contraindication
The decision to use adenosine-induced flow arrest during intracranial aneurysm surgery depends on a number of variables including location, size of the aneurysm, morphology and risk of rupture. In a recently published review of the use of adenosine during intracranial aneurysm surgery, Bendok et al. [17 • ] reported that the primary reason for using adenosine was to decrease intra-aneurysmal tension or ''soften the aneurysm''. Most aneurysms in this case series were located in the paraclinoid segment (35 %) or in the posterior circulation (22.5 %) [17 • ]. Adequate exposure of the aneurysm, its branches and perforators, is essential for safe and effective clipping of intracranial aneurysms.
This exposure is especially difficult to achieve in aneurysms that are deep or in close proximity to the skull base like the paraclinoid segment of the carotid artery and basilar apex. It is in these cases that we have found that intra-operative adenosine administration facilitates adequate exposure (see supplementary video 1). Aneurysm morphology with a broad neck [17 • ] and large size [18] also serve as indications to use adenosine for some neurosurgeons for similar reasons. In a recent case series, Loustarnien et al. [19] reported successful and uneventful clipping after intraoperative aneurysmal rupture facilitated by flow arrest induced by adenosine in 16 patients. The authors suggested that adenosine-induced flow arrest could be considered during intraoperative aneurysmal rupture when conventional suctioning fails to clear the field [19] .
Precautions
Adenosine acts via A 2B adenosine receptors on bronchial smooth muscles to cause muscle contraction [9] . Bebawy et al. [15 •• ] found no significant increase in peak airway pressures following bolus administration of adenosine in patients without reactive airway disease. Although there are several case reports of bronchospasm after adenosine administration, they have always been in patients with active asthma or chronic obstructive lung disease [20, 21] . In our experience, chronic smokers without the presence of severe reactive airway disease have not had any clinically relevant bronchospasm with adenosine. Therefore, in our opinion, adenosine administration as a bolus is best avoided in patients with severe reactive airway conditions such as asthma or chronic obstructive lung disease.
In the Adenoscan multicenter trial registry, it was found that 706 out 9,250 patients (7.6 %) undergoing stress testing with adenosine developed transient atrio-ventricular (AV) conduction block [22] . Makaryus et al. [23] reported the development of a persistent AV block in patients with pre-existing right bundle branch block after large doses of adenosine (47 mg over 5 min). Therefore, in our opinion anesthesiologists should be cautious about using adenosine in patients with pre-existing conduction defects.
Adenosine acts on the coronary vasculature to cause vasodilation, but in patients with cardiac ischemia there is a paradoxical increase in blood flow away to non-ischemic tissue (coronary vascular steal) [24, 25] . In a case report of two patients undergoing surgery for cerebral aneurysms, Owall et al. [26] reported the development of significant ST segment depression followed by sustained ventricular tachycardia in one patient and atrial flutter in the other, after administering adenosine. Both patients had a history of remote myocardial infarction (9 and 13 years, respectively). Bebawy et al. [15 • • ] recommended avoidance of adenosine-induced flow arrest in patients with evidence of severe (80 %) left main coronary artery stenosis, or severe multi-vessel coronary artery disease (three vessels or grafts with 80 % stenosis).
Finally, adenosine breakdown and uptake is inhibited by dipyridamole [13] , nimodipine [27] and methylxanthines [11] , leading to an increase in adenosine levels in these patients. In a study by Sollevi et al. [13] , patients were administered dipyridamole intraoperatively to reduce adenosine dose requirements during cerebral aneurysm clipping. The contraindications to adenosine use are summarized in Table 1 .
Intra-Operative Administration of Adenosine
The operative set up is similar to that in routine aneurysm surgery. All patients get routine intraoperative monitoring including a radial arterial line and a central venous line. We also place transcutaneous pacing pads on all our patients, as a precautionary measure, should pacing or cardioversion be required. The dose of adenosine is determined by administering escalating bolus amounts to produce a desired duration of arrest, starting with a 6 or 12 mg initial dose (in adults). We have usually found this to be approximately 1 mg/s of arrest, i.e., severe bradycardia and hypotension, but the response can vary widely with occasional unusual sensitivity or resistance. Bebawy et al. [ ; in our experience, these are self-terminating and generally resolve within minutes. A large case series (n = 98) describing adenosine induced asystole for endovascular aortic aneurysm repair reported a 2 % incidence of selflimited ST-segment depression on electrocardiography and a 4 % incidence of temporary heart block requiring \30 s of pacing [29] . Although the available evidence does suggest that transient ST-segment changes can be seen when adenosine is used to produce flow arrest in cerebral aneurysm surgery, there have been no reported cases of complete heart block requiring pacing or echocardiographic changes suggesting myocardial dysfunction [ While there is no high level evidence comparing adenosine flow arrest assisted aneurysm clipping to the conventional technique with temporary clipping, the available literature suggests that the intraoperative use of adenosine has an acceptable safety profile and surgical experience reaffirms that it is an effective tool in optimizing aneurysm exposure and ligation. The use of rapid ventricular pacing to create intra-operative flow arrest has been recently reported and may prove a useful alternative to adenosine for intracranial aneurysm surgery [30] .
Conclusion
Adenosine-assisted flow arrest in a useful technique to facilitate clip ligation of complex cerebral aneurysms. The available literature suggests that it can be used with adequate safety in carefully selected patients. The comparative efficacy of bolus adenosine to temporary clipping has not been studied, but it is clear that adenosine is a viable therapeutic option in cases where temporary clipping is high risk or technically infeasible and in cases of sudden unexpected intraoperative aneurysmal rupture. Neuroanesthesiologists should familiarize themselves with this technique and its application. 
